The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer. Read More >>
immunotherapy
June 1, 2019 · Monika Sharda, ASCO staff
February 11, 2019 · Greg Guthrie, ASCO Staff
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer. Read More >>
January 22, 2019 · Greg Guthrie, ASCO Staff
In this podcast, Cancer.Net Associate Editor Dr. Michael Williams describes lymphoma research advances presented at the American Society of Hematology Annual Meeting. Read More >>
January 8, 2019 · Greg Guthrie, ASCO staff
In this podcast, Dr. Brian Rini and Dr. Jorge Garcia discuss the latest research in genitourinary cancers presented at the 2018 ESMO Congress. Read More >>
December 20, 2018 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment. Read More >>
